S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Israel is quiet on next steps against Iran -- and on which partners helped shoot down missiles
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Israel is quiet on next steps against Iran -- and on which partners helped shoot down missiles
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Israel is quiet on next steps against Iran -- and on which partners helped shoot down missiles
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Israel is quiet on next steps against Iran -- and on which partners helped shoot down missiles
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
Olympic track uniforms spark online debate about who designed them and why they're so skimpy

Biora Therapeutics (BIOR) Short Interest Ratio & Short Volume

$0.67
-0.03 (-4.28%)
(As of 04/12/2024 ET)

Biora Therapeutics Short Interest Data

Current Short Volume
1,340,000 shares
Previous Short Volume
1,180,000 shares
Change Vs. Previous Month
+13.56%
Dollar Volume Sold Short
$1.47 million
Short Interest Ratio / Days to Cover
2.9
Last Record Date
March 31, 2024
Outstanding Shares
35,884,000 shares
Float Size
32,200,000 shares
Short Percent of Float
4.16%
Today's Trading Volume
300,071 shares
Average Trading Volume
574,227 shares
Today's Volume Vs. Average
52%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Biora Therapeutics ?

Sign up to receive the latest short interest report for Biora Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

BIOR Short Interest Over Time

BIOR Days to Cover Over Time

BIOR Percentage of Float Shorted Over Time

Biora Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/20241,340,000 shares $1.47 million +13.6%4.2%2.9 $1.10
3/15/20241,180,000 shares $1.32 million +4.4%4.8%2.9 $1.12
2/29/20241,130,000 shares $1.48 million +58.1%4.6%2.6 $1.31
2/15/2024714,600 shares $578,111.40 +12.0%2.9%1.1 $0.81
1/31/2024638,300 shares $600,002.00 +7.8%2.5%1 $0.94
1/15/2024592,300 shares $746,298.00 +32.0%2.3%0.9 $1.26
12/31/2023448,800 shares $605,880.00 -33.5%1.7%0.8 $1.35
12/15/2023674,800 shares $917,728.00 +130.3%2.6%1.3 $1.36
11/30/2023293,000 shares $363,320.00 -55.2%1.3%0.6 $1.24
11/15/2023653,700 shares $875,958.00 +28.6%2.9%3.9 $1.34
10/31/2023508,200 shares $988,449.00 +7.4%2.3%3.8 $1.95
10/15/2023473,100 shares $865,773.00 +9.2%2.2%4.2 $1.83
9/30/2023433,300 shares $940,261.00 +38.5%2.0%4.8 $2.17
9/15/2023312,800 shares $706,928.00 +69.5%2.4%3.5 $2.26
8/31/2023184,600 shares $548,262.00 -9.0%1.5%1.6 $2.97
8/15/2023202,800 shares $636,792.00 -14.9%1.7%1.2 $3.14
7/31/2023238,300 shares $912,689.00 -12.8%1.9%1.3 $3.83
7/15/2023273,300 shares $1.09 million -26.3%2.1%1.5 $4.00
6/30/2023370,800 shares $1.43 million -9.6%2.9%2.1 $3.85
6/15/2023410,000 shares $1.75 million -0.3%3.2%2.2 $4.28
5/31/2023411,100 shares $1.84 million +5.2%3.6%2.4 $4.48
5/15/2023390,700 shares $1.31 million -7.7%3.5%2.8 $3.35
4/30/2023423,100 shares $1.03 million +0.2%3.7%3.1 $2.43
4/15/2023422,100 shares $1.10 million -0.1%4.8%1.6 $2.60
3/31/2023422,400 shares $1.17 million +24.5%4.8%0.2 $2.77
3/15/2023339,400 shares $868,864.00 -17.3%3.9%0.2 $2.56
2/28/2023410,200 shares $1.26 million -0.5%4.9%0.2 $3.06
2/15/2023412,400 shares $1.43 million -33.9%6.1%0.2 $3.46
1/31/2023623,900 shares $2.60 million -74.1%9.2%0.3 $4.17
1/15/20232,410,000 shares $10.29 million +428.5%35.4%1.1 $4.27
12/30/2022456,000 shares $37.53 million -96.1%6.7%0.5 $82.31
12/15/202211,730,000 shares $2.05 million -1.9%6.9%8.1 $0.17
11/30/202211,960,000 shares $2.93 million -7.6%7.1%9.1 $0.25
11/15/202212,950,000 shares $3.46 million -6.6%7.7%10.4 $0.27
10/31/202213,860,000 shares $5.28 million -2.5%8.4%8 $0.38
10/15/202214,210,000 shares $5.76 million +0.9%8.6%8.4 $0.41
9/30/202214,080,000 shares $6.83 million -4.4%8.5%8 $0.48
9/15/202214,730,000 shares $9.95 million -0.1%8.9%7.5 $0.68
8/31/202214,750,000 shares $10.65 million -7.1%8.9%7.2 $0.72
8/15/202215,880,000 shares $16.52 million -1.2%9.6%7.4 $1.04
Bitcoin Rockets To Record High But Buy THIS Instead (Ad)

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

BIOR Short Interest - Frequently Asked Questions

What is Biora Therapeutics' current short interest?

Short interest is the volume of Biora Therapeutics shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 1,340,000 shares of BIOR short. 4.16% of Biora Therapeutics' shares are currently sold short. Learn More on Biora Therapeutics' current short interest.

What is a good short interest ratio for Biora Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BIOR shares currently have a short interest ratio of 3.0. Learn More on Biora Therapeutics's short interest ratio.

Which institutional investors are shorting Biora Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Biora Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Biora Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.16% of Biora Therapeutics' floating shares are currently sold short.

Is Biora Therapeutics' short interest increasing or decreasing?

Biora Therapeutics saw a increase in short interest in March. As of March 31st, there was short interest totaling 1,340,000 shares, an increase of 13.6% from the previous total of 1,180,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Biora Therapeutics' float size?

Biora Therapeutics currently has issued a total of 35,884,000 shares. Some of Biora Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Biora Therapeutics currently has a public float of 32,200,000 shares.

How does Biora Therapeutics' short interest compare to its competitors?

4.16% of Biora Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Biora Therapeutics: Indaptus Therapeutics, Inc. (1.71%), Synlogic, Inc. (0.63%), Onconova Therapeutics, Inc. (0.12%), KALA BIO, Inc. (0.25%), Lumos Pharma, Inc. (5.94%), Talphera, Inc. (0.70%), Allarity Therapeutics, Inc. (9.18%), Vincerx Pharma, Inc. (5.94%), Flora Growth Corp. (13.36%), Sol-Gel Technologies Ltd. (0.12%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

What does it mean to sell short Biora Therapeutics stock?

Short selling BIOR is an investing strategy that aims to generate trading profit from Biora Therapeutics as its price is falling. BIOR shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Biora Therapeutics?

A short squeeze for Biora Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BIOR, which in turn drives the price of the stock up even further.

How often is Biora Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BIOR, twice per month. The most recent reporting period available is March, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:BIOR) was last updated on 4/14/2024 by MarketBeat.com Staff

From Our Partners